<!DOCTYPE html>
<html lang="en">
  <head>
    <meta charset="UTF-8" />
    <meta name="viewport" content="width=device-width, initial-scale=1.0" />
    <title>SERM & Ancillary Library</title>
    <link rel="preconnect" href="https://fonts.googleapis.com" />
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin />
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet" />
    <style>
      :root {
        --bg: #0e0f11;
        --card: rgba(255, 255, 255, 0.04);
        --card-glow: rgba(0, 255, 204, 0.35);
        --accent: #00ffd0;
        --text: #eef3f7;
        --text-dim: #8392a7;
        --radius: 1.25rem;
        --transition: 0.6s cubic-bezier(0.19, 1, 0.22, 1);
      }
      *,*:before,*:after{box-sizing:border-box;margin:0;padding:0}
      body{font-family:"Inter",system-ui,sans-serif;background:var(--bg);color:var(--text);line-height:1.6;overflow-x:hidden}
      header{display:flex;justify-content:space-between;align-items:center;padding:1rem 1.5rem;max-width:1200px;margin:0 auto}
      a.logo{color:var(--text);font-weight:700;text-decoration:none}
      main{max-width:1200px;margin:0 auto;padding:2.5rem 1.5rem}
      h1{font-size:clamp(1.8rem,4vw,2.6rem);margin-bottom:1.75rem;position:relative}
      h1::after{content:"";position:absolute;bottom:-6px;left:0;width:64px;height:3px;background:var(--accent);border-radius:2px}
      .search-bar{width:100%;max-width:560px;margin:0 auto 2.2rem}
      .search-bar input{width:100%;padding:0.85rem 1rem;background:var(--card);border:1px solid transparent;border-radius:var(--radius);color:var(--text);font-size:1rem;transition:border 0.3s ease}
      .search-bar input:focus{outline:none;border-color:var(--accent)}
      .grid{display:grid;grid-template-columns:repeat(auto-fill,minmax(260px,1fr));gap:1.5rem}
      .card{background:var(--card);backdrop-filter:blur(22px) saturate(160%);border:1px solid rgba(255,255,255,0.06);border-radius:var(--radius);padding:1.5rem;position:relative;overflow:hidden;transform:translateY(20px);opacity:0;transition:var(--transition);cursor:pointer}
      .card.show{transform:none;opacity:1}
      .card::before{content:"";position:absolute;inset:0;background:linear-gradient(135deg,var(--card-glow) 0%,transparent 60%);opacity:0;transition:opacity 0.4s ease}
      .card:hover::before{opacity:1}
      .card h3{font-size:1.1rem;margin-bottom:0.35rem}
      .tag{display:inline-block;font-size:0.75rem;background:var(--accent);color:#000814;padding:2px 6px;border-radius:4px;font-weight:600;margin-bottom:0.9rem}
      .card p{font-size:0.88rem;color:var(--text-dim);white-space:pre-line}
      /* modal */
      .hidden{display:none !important}
      #modal{position:fixed;inset:0;background:rgba(0,0,0,0.7);backdrop-filter:blur(4px);display:flex;justify-content:center;align-items:center;padding:1.5rem;z-index:100;opacity:0;pointer-events:none;transition:opacity 0.4s ease}
      #modal.active{opacity:1;pointer-events:all}
      .modal-content{background:var(--card);border:1px solid rgba(255,255,255,0.08);border-radius:var(--radius);max-width:540px;width:100%;padding:2rem 1.75rem;position:relative;animation:fadeUp 0.45s ease}
      @keyframes fadeUp{from{transform:translateY(40px);opacity:0}to{transform:none;opacity:1}}
      .modal-content h3{margin-bottom:0.9rem;font-size:1.5rem}
      .close-btn{position:absolute;top:1.1rem;right:1.1rem;font-size:1.3rem;background:none;border:none;color:var(--text-dim);cursor:pointer;transition:color 0.3s ease}
      .close-btn:hover{color:var(--accent)}
      /* ——— quick-wins / medium extras ——— */
#disclaimerBanner{position:fixed;bottom:0;left:0;width:100%;padding:.6rem 1rem;
  background:var(--accent,#ea3546);color:#fff;display:flex;justify-content:space-between;
  z-index:999;font-size:.9rem}
#disclaimerBanner button{all:unset;font-size:1.2rem;cursor:pointer;margin-left:.8rem}

#filterToggle{position:fixed;top:1rem;right:1rem;padding:.45rem .9rem;border:0;
  background:var(--surface-3,#222);color:#fff;border-radius:6px;box-shadow:0 2px 6px rgba(0,0,0,.2);
  cursor:pointer;z-index:999}

#filterSidebar{position:fixed;top:0;right:0;width:260px;height:100vh;overflow-y:auto;
  background:var(--surface-1,#111);color:var(--text,#e2e8f0);padding:1rem;
  box-shadow:-4px 0 12px rgba(0,0,0,.3);transform:translateX(100%);
  transition:transform .3s ease;z-index:998}
#filterSidebar.open{transform:translateX(0)}

.chip{display:inline-block;margin:.15rem .25rem .15rem 0;padding:.15rem .55rem;
  font-size:.75rem;border-radius:9999px;background:var(--surface-2,#272b30);
  color:var(--text-dim,#a0aec0);cursor:pointer;user-select:none;transition:.2s}
.chip.active{background:var(--accent,#ea3546);color:#fff}

.riskGauge{display:block;height:8px;width:100%;border-radius:4px;margin-bottom:.4rem;
  background:linear-gradient(to right,#4caf50 0%,#ffc107 calc((var(--risk)-1)*25%),#f44336 calc((var(--risk)-1)*25%))}

    </style>
  </head>
  <body>
    <header>
      <a class="logo" href="index.html">← Home</a>
    </header>
    <main>
      <h1>SERMs & Ancillary Compounds</h1>
      <div class="search-bar"><input type="text" id="search" placeholder="Search SERMs / ancillaries…" /></div>
      <div class="grid" id="grid"></div>
    </main>

    <div id="modal" class="hidden" tabindex="-1"><div class="modal-content"></div></div>

    <script>
      /* ----------------------------- DATA -------------------------------- */
      const serms = [
  {
    name: "Arimidex (Anastrozole)",
    dose: "0.25–0.5 mg oral EOD",
    pros: "Non-steroidal AI; drops estradiol 70–80 % in hours",
    cons: "HDL ↓; joint dryness; rebound E2 if stopped abruptly",
    details: "Competitive CYP19A1 inhibitor used on-cycle to keep E2/bloat in range (ideal 20–35 pg/mL)."
  },
  {
    name: "Letrozole",
    dose: "0.25 mg oral E2D → titrate",
    pros: "Strongest oral AI; crushes estrogen rapidly",
    cons: "E2 crash → mood/libido loss; LDL ↑; bone de-mineralisation long-term",
    details: "Triazole AI that can drop E2 below assay detection within 48 h — reserved for emergency gyno flare control."
  },
  {
    name: "Exemestane (Aromasin)",
    dose: "12.5 mg oral EOD",
    pros: "Suicide (irreversible) AI; no rebound; mild androgenic boost",
    cons: "Costly; HDL ↓; liver enzymes may rise",
    details: "Steroidal AI binds aromatase covalently, permanently disabling the enzyme until new protein is synthesised."
  },
  {
    name: "Formestane",
    dose: "25 mg trans-dermal daily or 250 mg IM E3D",
    pros: "OTC suicide AI gel; local lipolysis claims",
    cons: "Skin irritation; weaker systemic effect than Exemestane",
    details: "4-hydroxy-androstenedione converts to inactive 4-oxo metabolites, knocking out aromatase with minimal hepatic impact."
  },

  /* ---------------- SERMs (Selective ER Modulators) ----------- */
  {
    name: "Tamoxifen (Nolvadex)",
    dose: "20 mg oral nightly",
    pros: "Blocks breast-tissue ERα → gyno prevention & PCT staple",
    cons: "Thrombo-embolism risk; hot flashes; lowers IGF-1",
    details: "SERM acting as ER antagonist in breast yet agonist in liver & bone; kick-starts LH/FSH when long-esters are cleared."
  },
  {
    name: "Clomiphene (Clomid)",
    dose: "50 mg oral nightly then taper",
    pros: "Powerful HPTA restart; raises LH/FSH 2- to 3-fold",
    cons: "Visual tracers; mood swings; brain fog at 100 mg+",
    details: "Mixture of zuclomiphene (long-acting) & enclomiphene (fast) that disinhibits GnRH by blocking estrogen feedback at the hypothalamus."
  },
  {
    name: "Raloxifene (Evista)",
    dose: "30–60 mg oral daily",
    pros: "Superior gyno reversal vs Tamox; lowers LDL; bone density ↑",
    cons: "Leg cramps; clot risk similar to Tamox",
    details: "Second-gen SERM with stronger ER antagonism in breast but weaker hepatic estrogenicity—popular for pubertal gyno management."
  },
  {
    name: "Toremifene (Fareston)",
    dose: "60 mg oral daily",
    pros: "Gentler on mood than Clomid; similar PCT efficacy",
    cons: "Expensive; QT-interval prolongation possible",
    details: "Chlorinated tamoxifen analog; raises LH/FSH without the visual distortions often seen with Clomid."
  },

  /* ---------------- 5-α-Reductase Inhibitors ------------------ */
  {
    name: "Finasteride",
    dose: "1 mg oral daily (hair) / 5 mg (prostate)",
    pros: "Cuts DHT ~65 %; slows androgenic alopecia; shrinks prostate",
    cons: "Post-finasteride libido issues (rare); slight T ↑ may raise E2",
    details: "Type-II 5-α-reductase blocker preventing T → DHT conversion in scalp & prostate."
  },
  {
    name: "Dutasteride",
    dose: "0.5 mg oral every other day",
    pros: "Inhibits type-I & II isozymes → DHT ↓ 90 %",
    cons: "Long t½ (5 wk) makes side-effects linger; PSA lab interference",
    details: "Dual 5-AR inhibitor offering stronger scalp protection but slower wash-out than Finasteride."
  },

  /* ---------------- Prolactin Control ------------------------- */
  {
    name: "Cabergoline",
    dose: "0.25 mg oral 2×/week",
    pros: "Drops prolactin 60–80 %; combats ‘Deca/Tren dick’",
    cons: "Orthostatic hypotension; nausea if taken empty stomach",
    details: "D2 receptor agonist with 63-h half-life, restoring dopamine tone suppressed by 19-nor compounds."
  },
  {
    name: "Pramipexole",
    dose: "0.125 mg oral HS titrate to 0.5 mg",
    pros: "Alternative for prolactin; improves REM sleep; antidepressant",
    cons: "Compulsive behaviour (gambling); morning nausea",
    details: "High-affinity D2/D3 agonist, shorter t½ than Caber—dose at night to leverage sedative effect."
  },
  {
    name: "Bromocriptine",
    dose: "2.5 mg oral QAM with food",
    pros: "Cheap ergoline DA agonist; lowers prolactin & may aid fat-loss",
    cons: "GI upset; dizziness; shorter action than Caber",
    details: "Older D2 agonist that also activates α-adrenergic pathways increasing basal metabolic rate modestly."
  },

  /* ---------------- Sympathomimetic Fat-loss ------------------ */
  {
    name: "Clenbuterol",
    dose: "20–120 µg oral (2-w on / 2-w off)",
    pros: "Potent β2 agonist thermogenesis; mild anti-catabolic",
    cons: "Tachycardia; cardiac hypertrophy long-term; tremors",
    details: "Stimulates β2-adrenergic receptors raising cAMP and body-temperature ~0.5 °C; desensitises after ~14 d."
  },
  {
    name: "Albuterol (Salbutamol)",
    dose: "4–8 mg oral pre-workout or 2–4 mg TID",
    pros: "Shorter half-life than Clen; less cardiac strain; legal inhaler",
    cons: "Shakiness; potassium ↓; needs 3–4 daily doses",
    details: "Rapid-acting β2 agonist giving 2–3 h thermogenic window—handy for fasted cardio."
  },
  {
    name: "Ephedrine (ECA stack)",
    dose: "25 mg + 200 mg caffeine TID (6 wk max)",
    pros: "Synergistic β1/β2/β3 + caffeine ↑ NE; appetite suppression",
    cons: "BP ↑; insomnia; receptor down-regulation",
    details: "Mixed adrenergic agonist plus aspirin/caffeine boosting cAMP & norepinephrine—classic cutting staple before Clen popularity."
  },
  {
    name: "Yohimbine HCl",
    dose: "0.2 mg/kg oral fasted AM",
    pros: "Alpha-2 antagonist targets stubborn hip/ab fat; libido ↑",
    cons: "Anxiety/jitters; BP ↑ in non-fasted state",
    details: "Blocks presynaptic α2 receptors, unleashing norepinephrine and blood-flow to adipose tissue—ineffective if insulin present."
  },

  /* ---------------- Thyroid & Mitochondrial -------------------- */
  {
    name: "T3 (Liothyronine)",
    dose: "25–75 µg oral split BID",
    pros: "Maximal metabolic rate ↑; synergistic with GH/Clen",
    cons: "Muscle catabolism; arrhythmia if overshot; needs taper",
    details: "Bioactive triiodothyronine bypasses T4→T3 conversion, accelerating ATP turnover and Na⁺/K⁺-ATPase activity."
  },
  {
    name: "T4 (Levothyroxine)",
    dose: "50–150 µg oral AM (empty stomach)",
    pros: "Gentler metabolism lift; smoother serum curve; cheap",
    cons: "Requires deiodinase conversion; slower onset",
    details: "Pro-hormone thyroxine provides steady pool for tissue-specific T3 synthesis, often stacked with GH in long cuts."
  },
  {
    name: "DNP (2,4-Dinitrophenol)",
    dose: "200 mg oral daily ×10–14 d (ADVANCED ONLY)",
    pros: "Fastest fat-loss (≈1 % body-wt/week) independent of diet",
    cons: "Hyperthermia, cataracts, death if mis-dosed; profuse sweating",
    details: "Mitochondrial proton-ionophore uncouples oxidative phosphorylation, forcing 50–60 % energy to dissipate as heat."
  },

  /* ---------------- Insulin-Sensitizers ------------------------ */
  {
    name: "Metformin",
    dose: "500–1,000 mg oral BID with meals",
    pros: "AMPK activation; lowers hepatic glucose output; may blunt AAS insulin-resistance",
    cons: "GI upset; B12 depletion; lactic acidosis in renal failure",
    details: "Biguanide that inhibits mitochondrial Complex-I raising AMP:ATP → AMPK, improving glucose disposal and lipid profile."
  },
  {
    name: "Berberine",
    dose: "500 mg oral TID",
    pros: "Metformin-like fasting glucose drop; gut-health benefits",
    cons: "GI cramp in some; CYP3A4 interactions",
    details: "Plant isoquinoline alkaloid activates AMPK & increases GLP-1, serving as an OTC insulin-sensitizer during bulk phases."
  },

  /* ---------------- PDE-5 Inhibitors --------------------------- */
  {
    name: "Sildenafil (Viagra)",
    dose: "25–100 mg oral PRN 30 min pre",
    pros: "Restores erectile firmness; pulmonary vasodilation",
    cons: "Headache; visual blue tint; BP ↓",
    details: "Selective PDE-5 blocker raising cGMP in corpus cavernosum for 4–6 h."
  },
  {
    name: "Tadalafil (Cialis)",
    dose: "5–20 mg oral PRN or 5 mg daily",
    pros: "36-h half-life (‘weekender’); mild BP support for Tren",
    cons: "Back pain; nasal congestion; interacts with nitrates",
    details: "Long-acting PDE-5 inhibitor also used at 5 mg ED to offset AAS-induced endothelial dysfunction."
  },
  {
    name: "Vardenafil (Levitra)",
    dose: "10–20 mg oral PRN",
    pros: "Faster onset than Sildenafil; less visual disturbance",
    cons: "Shorter duration (~5 h); dyspepsia",
    details: "PDE-5 blocker with slightly higher PDE-6 selectivity, giving strong rigidity at lower dose in some men."
  },
  {
    name: "Avanafil (Stendra)",
    dose: "100–200 mg oral PRN (15 min pre)",
    pros: "Quickest onset; fewer side-effects; food-independent",
    cons: "Costly; shortest real-world track record",
    details: "Next-gen PDE-5i reaching peak plasma in 30 min — convenient for spontaneous use."
  }
      ];

      /* --------------------- INIT --------------------------- */
      const grid = document.getElementById("grid");
      const searchInput = document.getElementById("search");

      const createCard = (c) => {
        const card = document.createElement("div");
        card.className = "card";
        card.dataset.name = c.name.toLowerCase();
        card.innerHTML = `
          <span class="tag">${c.dose}</span>
          <h3>${c.name}</h3>
          <p><strong>Pros:</strong>\n${c.pros}</p>
          <p style="margin-top:0.6rem"><strong>Cons:</strong>\n${c.cons}</p>
        `;
        card.addEventListener("click", () => openModal(c));
        return card;
      };

      const render = () => {
        serms.forEach((c) => grid.appendChild(createCard(c)));
        document.querySelectorAll(".card").forEach((el) => observer.observe(el));
      };

      /* ---------------- SEARCH ---------------- */
      searchInput.addEventListener("input", (e) => {
        const q = e.target.value.toLowerCase();
        grid.querySelectorAll(".card").forEach((card) => {
          card.style.display = card.dataset.name.includes(q) ? "block" : "none";
        });
      });

      /* ---------------- MODAL ---------------- */
      const modal = document.getElementById("modal");
      const modalContent = modal.querySelector(".modal-content");
      const openModal = (compound) => {
        modalContent.innerHTML = `
          <button class="close-btn" aria-label="Close modal">×</button>
          <h3>${compound.name}</h3>
          <p><strong>Standard Dose:</strong> ${compound.dose}</p>
          <p style="margin-top:0.9rem;white-space:pre-line;"><strong>Pros:</strong>\n${compound.pros}</p>
          <p style="margin-top:0.9rem;white-space:pre-line;"><strong>Cons:</strong>\n${compound.cons}</p>
        `;
        modal.classList.add("active");
        modal.classList.remove("hidden");
        modalContent.querySelector(".close-btn").addEventListener("click", closeModal);
      };
      const closeModal = () => {
        modal.classList.remove("active");
        setTimeout(() => modal.classList.add("hidden"), 300);
      };
      modal.addEventListener("click", (e) => { if (e.target === modal) closeModal(); });
      document.addEventListener("keydown", (e) => { if (e.key === "Escape" && modal.classList.contains("active")) closeModal(); });

      /* -------------- Scroll Reveal ------------- */
      const observer = new IntersectionObserver((entries, obs) => {
        entries.forEach((entry) => {
          if (!entry.isIntersecting) return;
          entry.target.classList.add("show");
          obs.unobserve(entry.target);
        });
      }, {threshold:0.15});

      render();
    </script>
    <script src="enhancements.js" defer></script>

  </body>
</html>
